ARCHIVES

NCI To Test 5,000 DC-Area Jews To Determine Risk Of BRCA 1 Mutation

This article is from The Cancer Letter archive.

Vol. 21 No. 38 | October 6, 1995

Download PDF Visit The Full Archive

Related Articles

Drug Development: FDA Grants Breakthrough Therapy Designation To CTL019 in ALL

June 11, 2014

NCAB Subcommittee Likes Organ Site Program, Except Smoking-Health

April 30, 1976

In Brief: DCT Board Rejects Move to Count Individual P01 Projects Toward The NIH Total Of 5,000 Grants

June 24, 1983

Committee Recommends FDA Approval Of Three New Drugs For Cancer Treatment

March 27, 1998

NCI Programs:Institute Informs Public About Thyroid Cancer Risk From Fallout.

January 3, 2003

DCPC Developing Hispanic Cancer Control Intervention Program Concept

August 12, 1988